In the present study, we provided molecular evidences that CD300A was a regulator of AKT phosphorylation, and loss of CD300A resulted in suppression of AKT phosphorylation and DLBCL cell growth both in vitro and in vivo. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.